Andrew Nathan Wilner, MD, FACP, FAAN

Suite 317, America Building

Newport, Rhode Island 02840

401.845.8366 office

401.369.9852 personal

401.662.1689 mobile

347.710.0103 fax

+63921.983.4322 international

Andrew@DrWilner.org

www.DrWilner.org

Education

Yale University, New Haven, Connecticut, BS Biology, 1977

Brown University Medical School, Providence, RI, MD, 1981

Medical Internship

Long Beach Veterans Hospital, University of California, Irvine, 1981

Residencies

Internal Medicine, Los Angeles County-University of Southern California Medical Center, 7/83-6/85

Neurology, McGill University Affiliated Hospitals, 7/85-6/88

Fellowship

Electroencephalography, Montreal Neurological Institute, McGill University, 7/88-7/89

Professional Licenses and Board Certifications

1994 Added Qualification in Clinical Neurophysiology

1989 Diplomate of American Board of Psychiatry and Neurology

1985 Diplomate of American Board of Internal Medicine

Licensed in Rhode Island and Massachusetts

Professional Memberships

American Epilepsy Society, American Academy of Neurology, American College of Physicians

Clinical Appointments

1998-1999 Clinical Associate Professor of Neurology, Brown University

1996-1997 Clinical Assistant Professor, Department of Medicine and Neurology, School of Medicine, University of North Carolina at Chapel Hill

1994-1997 Adjunct Associate Professor of Psychology, University of North Carolina, Charlotte

Clinical Practice

1989-1997 Neurologist, Carolina Neurological Clinic, 1001 Blythe Blvd, Suite 601, Charlotte, NC 28203

1991-1997 Medical Director, Carolinas Epilepsy Center, Carolinas Medical Center, Charlotte, NC

1991-1997 Part-time Faculty, Department of OB-GYN, Epilepsy and Pregnancy Clinic, Carolinas Medical Center, Charlotte, NC

7/82-6/83 Emergency Room Physician, Bellwood General Hospital, Bellflower, California

Current Activities

Medical Writer/Editor. Medical Advisory Board for Accordant Health Services, Inc., Neurology Advisory Board for Vivicare and Advisory Board of the American Academy of Neurology Website. Reviewer for Annals of Internal Medicine (Top 10%,2007), Epilepsia, Epilepsy and Behavior, and Neurology.

Research

1. Evaluation of equivalency of generic and brand name antiepileptic drugs 2002-present.

2. Investigator-an evaluation of lamotrigine versus carbamazepine, phenytoin, or divalproex sodium as monotherapy treatment for epilepsy patients who have failed a previous course of antiepileptic drug therapy, 5/98-1/99.

3. Investigator-a multivariate analysis of health status scores in patients with epilepsy, 7/22/97-1/1/98.

4. Investigator-rufinamide in generalized epilepsy, 3/97-12/97.

5. Investigator-ganaxolone in infantile spasms, 6/96-97.

6. Investigator-oxcarbazepine pediatric study, 6/96-12/97.

7. Investigator-UCB LO59, 9/94-12/97.

8. Investigator-vigabatrin, 9/94-12/97.

9. Investigator-vagal nerve stimulator, E04, 9/94-9/97.

10. Investigator-tiagabine phase III clinical trial, 1/93-12/97.

11. Investigator-gabapentin, 9/94-8/95.

12. Investigator-felbamate compassionate use antiepileptic drug program, 8/92-8/93.

13. Investigation of evoked potential response to auditory and electrical stimuli in teleost and elasmobranch fish. Post-doctoral scholar in neurophysiology at Scripps Institute of Oceanography, La Jolla, California, 7/84-9/84.

14. Stroboscopic applications to hydrodynamics study of swimming fish, Brachydanio rerio and Carassius auratus. Yale University Biology Department, 1/76-1/77.

15. Direct measurement with miniature pressure transducers and accelerometers of stresses encountered by swimming fish, Pomatomus saltatrix. Marine Biological Laboratory, Woods Hole, Massachusetts and the John B. Pierce Foundation, New Haven, Connecticut, 6/76-9/76.

16. Study of renal lithiasis at Yale Medical School, 5/75-8/75.

17. High speed cinematography used to investigate jaw mechanics of the primitive teleost fishes, the Osteoglossoidei. Yale Biology Department, 1/74-8/75.

18. Research assistant on specimen collecting trip through Central America to Panama, 1/74-8/74.

19. Research assistant at the Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, 3/73-9/73.

Books

1. Epilepsy in Clinical Practice. Demos Medical Publications, New York, November, 2000.

2. Epilepsy: 199 Answers (A Doctor Responds to His Patients’ Questions). Demos Vermande, New York, September, 1996, second edition, 2003, third edition, 2008.

Publications

1. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15(3):137-41.
2. Harden et al. Women and epilepsy practice parameter (in preparation).
3. Wilner AN. Therapeutic equivalency of generic antiepileptic drugs-results of a survey. Epilepsy and Behavior 2004;5/6:995-998.
4. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner, A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1252-60.
5. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy; report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62(8):1261-73.
6. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:401-409.
7. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2004;45:410-423.
8. Wilner AN. Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem. Epilepsy and Behavior 2002; 13(6):522-525.
9. Sheen VL, Dixon PH, Fox JW, Hong SE, Kinton L, Sisodiya SM, Duncan JS, Dubeau F, Scheffer IE, Schachter SC, Wilner A, Henchy R, Crino P, Kamuro K, DiMario F, Berg M, Kuzniecky R, Cole AJ, Bromfield E, Biber M, Schomer D, Wheless J, Silver K, Mochida GH, Berkovic SF, Andermann F, Andermann E, Dobyns WB, Wood NW, Walsh CA. Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet 2001;10 (17):1775-83.
10. Glauser TA, Nigro M, Sachdeo R, Pasteris LA, Weinstein S, Abou-Khalil B, Frank LM, Grinspan A, Guarino T, Bettis D, Kerrigan J, Geoffroy G, Mandelbaum D, Jacobs T, Mesenbrink P, Kramer L, D’Souza J, and the Oxcarbazepine Pediatric Study Group. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 2000;54:2237-2244 (participant).
11. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik, I and the United States Levetiracetam Study Group: Levetiracetam for partial seizures. Results of a double-blind, randomized clinical trial. Neurology 2000;55:236-242 (participant).
12. Wilner AN, Raymond, KH and Pollard, RJ: Topiramate and metabolic acidosis. Epilepsia 1999;40:792-795.
13. Schachter SC, Ito M, Wannamaker B, Rak I, Ruggles K, Wilner A, Jackel R, Gilliam F, Morris G, Skantz J, Sperling M, Buchhalter J, Drislane F, Ives J, Schomer D: Incidence of spikes and paroxysmal rhythmic events in overnight ambulatory computer-assisted EEGs of normal subjects: a multicenter study. J. Clinical Neurophysiology 1998;15:251-255.
14. The STIPAS Investigators: Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). Stroke, 1994, Vol. 25, No. 2, pp. 418-423 (participant).
15. Wilner AN and Bream PR: Status epilepticus and pseudostatus epilepticus. Seizure, 1993;2:257-260.
16. Gewitz H, Wilner A, Garriepy S, Ree HJ, and Most A: A diagnosis of left-ventricular mural thrombus by means of radionuclide ventriculography. J. of Nuclear Medicine, 1981, 22:610-612.
17. Skinner HCW, Osbaldiston GW, and Wilner AN: Monohydrocalcite in a guinea pig bladder stone, a novel occurrence. American Mineralogist, 1977, 62:273-277.

Abstracts

1. Wilner AN: International League Against Epilepsy creates online discussion group. Epilepsia 2006, Vol 47, Suppl 4.

2. Wilner AN: Results of switching to generic antiepileptic drugs in the treatment of epilepsy. Epilepsia 2004, Vol 45, Suppl. 7, p. 138.

3. Wilner AN: Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem. Epilepsia 2002, Vol. 43, Suppl. 7, p. 203.

4. Wilner AN and Eisenberg DP: Repeat electroencephalograms in patients presenting with syncope versus seizure. Epilepsia, 1999, Vol. 40, Suppl. 7, p. 166.

5. Wilner AN and Bivens JG: Efficacy, tolerability, and weight loss in adults with intractable epilepsy on the ketogenic diet. Epilepsia, 1998, Vol. 39, Suppl. 6, p. 195.

6. Dodson WE, Bourgeois BFD, Shields WD, Kerrigan JF, Bluestone DL, Nelson TY, Wilner AN, Pellock JM, Morton LD, Densel MB, Lee DA, Monaghan EP: Ganaxalone in the treatment of refractory infantile spasms. Dublin Epilepsy Meeting, June, 1997.

7. Wilner AN, Band-Presnell A, Dozier F, Tarver WB: Magnet activation of the vagal stimulator provides additional seizure control. Epilepsia, 1996, Vol. 37, Suppl. 5, p. 92.

8. Connell BE, Wilner AN: MMPI-2 distinguishes intractable epilepsy from pseudoseizures: a replication. Epilepsia, 1996, Vol. 37, Suppl. 5, p. 19.

9. Wilner AN, Arnold PB, Ballinger WE: Relative value of PET and SPECT in presurgical epilepsy patients. Epilepsia, 1995, Vol. 36, Suppl. 4, p.14.

10. Connell BE, Wilner AN: Assessment of personality, adjustment to seizures, and quality of life in patients with intractable epilepsy versus pseudoseizures. Epilepsia, 1995, Vol. 36, Suppl. 4, p.101.

11. Connell BE, Harver A, Tebbutt D, Wilner AN: Assessment of quality of life by QOLI and QOLIE yields differential effects in patients with intractable epilepsy vs pseudoseizures. Archives of Clinical Neuropsychology, 1996, Vol. 11, No. 5, pp. 377-378.

12. Tebbutt D, Harver A, Wilner AN: Evaluating quality of life in difficult epilepsy with the QOLIE-89: Comparisons between seizure and pseudoseizure patients. Epilepsia, 1995, Vol. 36, Suppl. 4, p. 102.

13. Wilner AN, Farkouh M: Pseudoseizures in the elderly. Epilepsia, 1994, Vol. 35, Suppl. 8, p.11.

14. Brockway JP, Follmer RL, Wilner AN, Naegele CS: Temporal lobe epilepsy adversely affects the long-term ability to see a face and say the name of this face: Epilepsia, 1994, Vol. 35, Suppl. 8, p. 74.

15. Bustamente D, Harver A, Wilner A: Intellectual function, psychopathology, and psychosocial assessment in epilepsy and pseudoseizure: A prospective evaluation. Epilepsia, 1994, Vol. 35, Suppl. 8, p. 78.

16. Wilner AN, Loring C, Connell B, Arnold PB: Gender ratio of nonepileptic seizures varies as a function of age. Epilepsia, 1993, Vol. 34, Suppl. 6, p. 29.

17. Wilner AN, Connell B: Correct prediction of right and left temporal lobe seizure foci using tests of design and verbal learning. Epilepsia, 1993, Vol. 34, Suppl. 6, p. 87.

18. Stewart JD, Wilner A: Are new F-response parameters more sensitive in detecting abnormalities than the traditional minimal latency measurements and which new parameters are the most sensitive? (AAEE, San Diego, 1988).

19. DuBois AB, Fox RS, Wilner AN: Gravitational tolerance in Bluefish (Pomatomus saltatrix). Federation Proceedings, 1977, No. 3, 36:443.

20. DuBois AB, Fox RS, Wilner AN, Lambertson RH: Blood pressure and locomotion in Bluefish (Pomatomus saltatrix). Biological Bulletin, 1976, No. 2, 151:407.

Fiction

1. The one that got away. Toowrite.com; 2002; www.toowrite.com/comp6/0152.shtml.

2. That’s it! Neurology, 2002, Vol. 58, No. 1, p. 152.

3. At the doctor’s office, Annals of Internal Medicine, 1995, Vol. 123, No. 5, p. 388.

4. Michael LaCombe, Ed. On being a doctor, Her daughter in my office. American College of Physicians, 1995.

5. A class revisited, Mediphors, Spring 1994, No. 3, p. 54.

6. The smile, Mediphors, Spring 1993, No. 1, p. 31.

7. Her daughter in my office, Annals of Internal Medicine, 1992, Vol. 116, No. 12, p. 1031.

8. Jessica Bryan, Ed. Love is ageless, I know, Dr. Alzheimer, Serala Press, Oakland, California, 1987, pp. 9-14.

9. Life with Harry, The Yale Literary Magazine, 1977, Vol. 146, No. 1, p. 28.

Films

1. The Last Sentence (2005) (Screenplay) (2005 Newport International Film Festival-open call)

2. Polar Bear Plunge (2006) (Documentary 16.5 minutes) (2006 Newport International Film Festival-open call)

Other Publications

1. The death of Churchill. Woods Hole Currents 2005;10(4):15.

2. A guide to controlling seizures. Living with Epilepsy 2004;5(4):4-6.

3. New director lands at bird sanctuary. Newport This Week, April 1, 2004.

4. Letter to the editor. Alert Diver, March/April, 2004, pp 4-5.

5. Winter is prime time for seal spotting. Newport This Week, January 8, 2004, pp 6, 23.

6. Physicians and the press: What to say, what not to say. Medical Economics, July 11, 2003;80:87.

7. Book Review. Lucky Man: A Memoir. Journal of American Medical Association 2002;288:2337-8.

8. Schachter SC and Schmidt D, editors. 110 Puzzling Cases of Epilepsy, pp. 168-171. Martin Dunitz Ltd, London, 2002.

9. When it’s right to be wrong. Cortlandt Forum, June 1999, Volume 12, Number 6, p. 71.

10. New medication options for patients with epilepsy. Medicine and Health/Rhode Island, December 1998, Volume 81, Number 12, pp. 406-7.

11. Schachter SC and Rowan AJ, editors: The Brainstorms Healer, pp. 64-66, Lippincott-Raven, Philadelphia, PA, 1998.

12. Ask the doctor. Charlotte Observer, January 13, 1997.

13. Lessons of a dilated pupil. Cortlandt Forum, May 1996, Volume 9, Number 5, pp. 146-7.

14. Downside of generics isn’t news to MD’s. Charlotte Observer, March 28, 1996 (letter).

15. Walking wounded. Cortlandt Forum, February 1996, Volume 9, Number 2, p. 61.

16. When one diagnosis is not enough. Cortlandt Forum, December 1995, Volume 8, Number 12.

17. Ask the doctor. Charlotte Observer, October 16, 1995.

18. Online: Diagnosis and Information via the Internet. Mecklenburg County Medical Society Bulletin, October 1995, p. 17.

19. Info highway lets doctors pool our skills. Charlotte Observer, Thursday, July 13, 1995.

20. An elderly woman with acute altered mental status. Physician Assistant Magazine, November 1995, Volume 19, Number 11.

21. ‘Small’ spells are also seizures. Cortlandt Forum, February 1995, Volume 8, Number 2 (letter).

22. Book Review, Journal of American Medical Association, 1995, Volume 273, Number 10, p. 823.

23. Ask the doctor. Charlotte Observer, January 2, 1995.

24. The healing hand. North Carolina Medical Journal, December 1994, Volume 55, Number 12.

25. Book review. Journal of American Medical Association, 1994, Volume 271, Number 3, p. 246.

26. Wilner AN: Efficacy of felbamate monotherapy. Annals of Neurology, June 1993, Volume 33, Number 6, p. 661 (letter).

27. Ask the doctor. Charlotte Observer, April 5, 1993.

28. There’s magic mingling with the manatees. Charlotte Observer, Thursday, April 1, 1993.

29. Book review. Journal of American Medical Association, 1992, volume 267, Number 11, pp. 1540-1.

30. Editors, Matthews PM, Arnold DL. Diagnostic tests in neurology. Book chapter, Evoked potentials in the evaluation of visual and auditory pathways. Churchill-Livingstone, 1991.

31. Running into trouble. Cortlandt Forum, September 1992, p. 66.

32. Ask the doctor. Charlotte Observer, March 25, 1991.

Applied Neurology

1. Is there a BENEFIT to treating CIS early? July 2007;3(7):41-42.

2. Hedonistic homeostatic dysregulation syndrome: Too much of a good thing? 2006;1(10):35-36.

3. Advances in neurorehabilitation: Turning thoughts into action. July 2006, pp D3, D4, D6.

4. New vs old AEDs. 2005;1 (11):14-26.

Pulmonary Reviews

1. Hypoxia impairs glucose metabolism, spares sleep architecture. September 2007, Vol 12, No 9, p 30.

EpilepsyUSA

1. Sudden unexpected death in epilepsy (SUDEP)-rare but deadly. 2008, issue 2, p 17,18.

CNS News

1. Overinterpretation of EEGs leads to misdiagnosis of epilepsy. May 2008, Vol 10, No 1, p 13.

2. FDA: Antiepileptic drugs increase risk for suicide. May 2008, Vol 10, No 1, p 13.

3. Genetic heterogeneity of MS patients influences response to β-interferon. May 2008, Vol 10, No 1, p 9.

4. Autism susceptibility gene identified. April 2008, Vol 10, No 4, p 7.

5. Minocycline improves stroke outcomes. April 2008, Vol 10, No 4, p 13.

6. Phase II trial of methotrexate shows positive outcomes for some lymphoma patients. April 2008, Vol 10, No 4, p 14.

7. SANAD study offers recommendations for partial, generalized, unspecialized seizure treatment. April 2008, Vol 10, No 4, p 15.

8. Study: air pressure does not affect seizure frequency. April 2008, Vol 10, No 4, p 15.

9. Childhood mood problems may occur in epilepsy. February 2008, Vol 10, No 2, p 1,7,8.

10. Familial and sporadic hemiplegic migraine share genetic link. February 2008, Vol 10, No 2, p 11.

11. Interferon beta-1b delays disability in BENEFIT study. February 2008, Vol 10, No 2, p 11.

12. Developmental delay associated with antiepileptic drugs in India. October 2007, Vol 9, No 10, p 35.

13. Genetic polymorphism speeds carbamazepine metabolism. October 2007, Vol 9, No 10, p 18.

14. Antiepileptic drug prescriptions often not refilled. October 2007, Vol 9, No 10, p 18.

15. Researchers find sleep disturbances common in menopause. October 2007, Vol 9, No 10, p 12, 17.

16. Brief test of wakefulness effective in healthy subjects. October 2007, Vol 9, No 10, p 12.

17. Study shows strong link between shift work, poor sleep in police officers. October 2007, Vol 9, No 10, p 12.

18. Study confirms efficacy of rotigotine patch in calming restless legs. September 2007, Vol 9, No 9, p 10.

19. STOP questionnaire screens sleep apnea preoperatively. September 2007, Vol 9, No 9, p 10.

20. Premenstrual dysphoric disorder found to be common in epilepsy. August 2007, Vol 9, No 8, p 1, 29.

21. Few individuals with nonepileptic seizures have true epilepsy. August 2007, Vol 9, No 8, p 28, 30.

22. AAN tackles issue of generic antiepileptic drugs. July 2007, Vol 9, No 7, p 10, 11.

23. Involuntary emotional expression disorder underdiagnosed. July 2007, Vol 9, No 7, p 15.

24. Small study supports theory that meditation can improve seizure control. June 2007, Vol 9, No 6, p 16, 30.

25. Stat EEGs expose subclinical status epilepticus. May 2007, Vol 9, No 5, p 20.

26. Inadequate vitamin D levels found in children with intractable epilepsy. May 2007, Vol 9, No 5 p 20, 39.

27. Sleep disturbances are common comorbities in epilepsy patients. May 2007, Vol 9, No 5, p 21.

28. Deep brain stimulation lowers medication costs in men in small study. May 2007, Vol 9, No 5, p 34.

29. Teens with epilepsy shun group sports. April 2007, Vol 9, No 4, p 1, 29.

30. Impulse dyscontrol may occur in patients with Parkinson’s disease. April 2007, Vol 9, No 4, p 1, 29.

31. Cognitive impairment decreases function in Parkinson’s disease. April 2007, Vol 9, No 4, p 6.

32. Gene associated with seizure susceptibility. April 2007, Vol 9, No 4, p 11.

33. Study: Epilepsy treatment improves language function in children. April 2007, Vol 9, No 4, p 12, 23.

34. New onset juvenile myoclonic epilepsy associated with cognitive deficits. April 2007, Vol 9, No 4, p 13.

35. Wireless EEG speeds diagnosis of epilepsy in the emergency room. April 2007, Vol 9, No 4, p 13.

36. Elevated tumor necrosis factor found in cerebrospinal fluid of autistic children. April 2007, Vol 9, No 4, p 18.

37. Human endogenous retrovirus-K18 increases risk for multiple sclerosis. April 2007, Vol 9, No 4, p 24.

38. Study sheds light on genetics of severe multiple sclerosis. April 2007, Vol 9, No 4, p 24.

39. Neutralizing antibodies block effects of MS therapy. April 2007, Vol 9, No 4, p 25.

40. eNos gene associated with vasospasm. March 2007, Vol 9, No 3, p 10.

41. Continuous EEG monitoring assists in subarachnoid hemorrhage prognosis. March 2007, Vol 9, No 3, p 10.

42. Screening tool reveals depression in epilepsy patients. March 2007, Vol 9, No 3, p 18, 34.

43. C-reactive protein predicts brain edema. March 2007, Vol 9, No 3, p 23.

44. Gamma knife surgery decreases seizures, preliminary data suggest. March 2007, Vol 9, No 3, p 24.

45. Atkins diet may decreases seizures in patients with intractable epilepsy. March 2007, Vol 9, No 3, p 24.

46. Psychiatric history affects epilepsy surgery outcome. March 2007, Vol 9, No 3, p 27.

47. Metabolic disease common in severe pediatric epilepsy. March 2007, Vol 9, No 3, p 27.

48. Underestimated ADHD prevalence seen in pediatric epilepsy. February 2007, Vol 9, No 2. p 1, 10.

49. TAT associated with stroke outcome. February 2007, Vol 9, No 2, p 26.

50. Impulse dyscontrol may occur in patients with Parkinson’s disease. February 2007, Vol 9, No 2, p 27.

51. PET shown to differentiate dementia types. January 2007, Vol 9, No 1, p 22, 23.

52. Acute stroke often followed by seizures in children October 2006, Vol 8, No 10, p 14.

53. Study examines rates of carotid imaging in TIA and stroke. October 2006, Vol 8, No 10, p 14, 15.

54. Low yield seen for echocardiography in ischemic stroke. October 2006, Vol 8, No 10, p 15.

55. Early treatment with spinal cord stimulation likely to succeed. October 2006, Vol 8, No 10, p 40.

56. Sleep apnea symptoms slip by the QOLIE 89. September 2006, Vol 8, No 9, p 35.

57. Sleep apnea may impair stroke recovery-at least on imaging. September 2006, Vol 8, No 9, p 35.

58. Stroke recovery not affected by presence of comorbidities, study shows. September 2006, Vol 8, No 9, p 36.

59. Extreme blood pressure a poor prognostic sign after stroke. September 2006, Vol 8, No 9, p 36.

60. Study described idiopathic intracranial hypertension in children. September 2006, Vol 8, No 9, p 34.

61. Rapid relief of migraine and Allodynia seen with occipital nerve block. September 2006, Vol 8, No 9, p 28.

62. ALS patients at high risk of deep vein thrombosis. September 2006, Vol 8, No 9, p 39.

63. Splitting headache experts: The debate over migraine surgery. September 2006, Vol 8, No 9, p 1, 30, 31.

64. Oral contraceptive use associated with less disability in MS. August 2006, Vol 9, No 8, p 1, 25.

65. Interferon delays development of multiple sclerosis. August 2006, Vol 9, No 8, p 25.

66. Ketogenic diet reduces long-term incidence of seizures. August 2006, Vol 9, No 8, p 34, 35.

67. Orthopedic surgery well tolerated by patients with Parkinson’s disease. August 2006, Vol 9, No 8, p 47.

68.         &nb